Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Evangelos S. Felekouras

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2988-4116; OpenAlex author ID A5053612880, A5108832783. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 7 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 12

  1. Exploring the Link Between Nutritional and Functional Status and Short-Term Postoperative Outcomes in Patients Undergoing Pancreatic Cancer Surgery. Co-author DOI 10.3390/life15050803↗
  2. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genom… Co-author DOI 10.3390/cancers16010002↗
  3. Role and Efficacy of Robotic-assisted Radical Antegrade Modular Pancreatosplenectomy (RAMPS) in Left-sided Pancreatic Cancer. Co-author DOI 10.21873/cdp.10088↗
  4. The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis. Co-author DOI 10.1007/s00268-020-05821-7↗
  5. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC). Last author DOI 10.1097/coc.0000000000000826↗
  6. Combinatorial Treatment of Tinzaparin and Chemotherapy can Induce a Significant Antitumor Effectin Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-551892/v1↗
  7. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice. Last author DOI 10.2217/pme-2021-0031↗
  8. The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study. Co-author DOI 10.3390/cancers13122884↗
  9. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. First author DOI 10.3390/cancers13215532↗
  10. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. Co-author DOI 10.3390/ijms22137053↗
  11. Unique Spatial Immune Profiling in Pancreatic Ductal Adenocarcinoma with Enrichment of Exhausted and Senescent T Cells and Diffused CD47-SIRPα Expression. Co-author DOI 10.3390/cancers12071825↗
  12. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07261-7↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dimitriοs Schizas · 7 shared papers, 2021–2025 · strength 0.96
  2. Alexandros Papalampros · 6 shared papers, 2020–2022 · strength 0.73
  3. Michalis V. Karamouzis · 4 shared papers, 2021 · strength 0.48
  4. Stratigoula Sakellariou · 3 shared papers, 2020–2023 · strength 0.45
  5. Michail G. Vailas · 3 shared papers, 2020–2025 · strength 0.43
  6. Pavlos Papakotoulas · 3 shared papers, 2021 · strength 0.36
  7. Panagiotis Sarantis · 3 shared papers, 2021 · strength 0.36
  8. Dimitrios Moris · 3 shared papers, 2019–2021 · strength 0.35
  9. Stamatios E Theocharis · 2 shared papers, 2021 · strength 0.25
  10. Evangelos Koustas · 2 shared papers, 2021 · strength 0.25
  11. Athanasios G. Papavassiliou · 2 shared papers, 2021 · strength 0.25
  12. Kostas Palamaris · 1 shared paper, 2021 · strength 0.22
  13. Maximos Frountzas · 1 shared paper, 2025 · strength 0.22
  14. Dimitrios Stefanoudakis · 1 shared paper, 2025 · strength 0.22
  15. Irene Lidoriki · 1 shared paper, 2025 · strength 0.22
  16. Konstantinos G. Toutouzas · 1 shared paper, 2025 · strength 0.22
  17. Eleandros Kyros · 1 shared paper, 2022 · strength 0.17
  18. Nikolaos I. Nikiteas · 1 shared paper, 2022 · strength 0.17
  19. Dimitrios C. Ziogas · 1 shared paper, 2023 · strength 0.14
  20. Ioannis Boukovinas · 1 shared paper, 2023 · strength 0.14
  21. George Nasioulas · 1 shared paper, 2023 · strength 0.14
  22. Charalampos Theocharopoulos · 1 shared paper, 2023 · strength 0.14
  23. Maria G Sotiropoulou · 1 shared paper, 2021 · strength 0.13
  24. Konstantinos P. Toutouzas · 1 shared paper, 2021 · strength 0.13
  25. Athanasios S. Petrou · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.